COVID Vaccine | Photo by Soham Parikh | Edited by Kayli Thompson | The Wright State Guardian
The US Food and Drug Administration’s (FDA) issued the emergency use authorization of the Pfizer coronavirus vaccine, raising questions and concerns for the public.
Breakdown of the Pfizer vaccine
Since beginning development 11 months ago, this vaccine has come under question for its safety and effectiveness, it especially came under fire in the 2020 election cycle.
In regards to the Pfizer vaccine, the CDC and FDA both advocate for its safety and effectiveness, with the CDC claiming that it is 95% effective against preventing Covid-19. The FDA assures the public that the Pfizer vaccine is safe and has few side effects.
According to the CDC, the Pfizer vaccine is an mRNA vaccine that requires two doses about two weeks apart. Those in trials have experienced flu-like symptoms, which is the body’s immune system initiating protection against possible coronavirus pathogens.
Despite getting a vaccine, the public will still have to follow covid safety measures and wear masks, especially during the period between the first and second doses.
Distribution of the vaccine is proving to be a logistical nightmare. Each state has plans in place to distribute the vaccine, register providers for the vaccine and who is first in line to get the vaccine.
According to Gov. Mike DeWine’s plan, Ohio has already ordered 98,475 doses of the Pfizer vaccine to be delivered on or around Dec. 15. Providers for the vaccine will include hospitals, medical institutions, and drug stores like Walgreens.
According to the FDA, the vaccine will be made available to the public at no cost, however, providers can charge their own fees. Most fees will be covered by insurance. The first to get these vaccines will be health care professionals and those in medical institutions.
Despite the safety and effectiveness of the vaccine, there are still concerns. Pfizer is still continuing research and trials to see the vaccine’s effect on those under 18, pregnant persons, and how it will impact minority communities.
According to the FDA, Pfizer will continue to conduct clinical trials with these groups in mind to ensure the safest vaccine for these groups.